SCHEMBL18627898

SCHEMBL18627898

CC1(C)C(=O)NCCN1c1ncc(-c2cccc(Nc3nccc(N4CCCC4)n3)c2)o1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.56
▸ SMG1 Q96Q15 8/20 0.39
▸ CDK1 P06493 4/20 0.39
▸ CDK2 P24941 4/20 0.39
▸ MTOR P42345 4/20 0.38
▸ HRH4 Q9H3N8 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37
▸ CAMK2D Q13557 2/20 0.37
▸ FLT1 P17948 1/20 0.36
▸ FLT4 P35916 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ NFKB1 P19838 2/20 0.36
▸ NR2C2 P49116 2/20 0.36
▸ NFKB2 Q00653 2/20 0.36
▸ RELA Q04206 2/20 0.36
▸ TAB1 Q15750 2/20 0.36
▸ JAK2 O60674 2/20 0.36
▸ ALK Q9UM73 2/20 0.36
▸ ZAP70 P43403 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18627934 0.95 SYK (0.56) SYKSMG1CDK1CDK2MTOR
SCHEMBL18627907 0.94 SYK (0.54) SYKSMG1CDK1CDK2MTOR
SCHEMBL18627953 0.88 SYK (0.61) SYKSMG1CDK1CDK2MTOR
SCHEMBL18652274 0.88 SYK (0.58) SYKSMG1CDK1CDK2CAMK2D
SCHEMBL18652487 0.87 SYK (0.45) SYKSMG1CDK1CDK2MTOR
SCHEMBL18627906 0.86 SYK (0.57) SYKSMG1CDK1CDK2MTOR
SCHEMBL18627929 0.86 SYK (0.57) SYKSMG1CDK1CDK2MTOR
SCHEMBL18627938 0.86 SYK (0.57) SYKSMG1CDK1CDK2MTOR
SCHEMBL18627897 0.85 SYK (0.56) SYKSMG1CDK1CDK2MTOR
SCHEMBL17113289 0.85 SYK (0.67) SYKSMG1CDK1CDK2MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3350176-B1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2021-04-28 — — EP claimed
US-10392373-B2 Oxazole derivatives that inhibit Syk AB SCIENCE (FR) 2019-08-27 — — US claimed
US-20190055230-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2019-02-21 — — US claimed
EP-3144307-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB Science (FR) 2017-03-22 — — EP claimed
EP-3350176-B1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2021-04-28 — — EP disclosed
US-10392373-B2 Oxazole derivatives that inhibit Syk AB SCIENCE (FR) 2019-08-27 — — US disclosed
US-10392373-B2 Oxazole derivatives that inhibit Syk AB SCIENCE (FR) 2019-08-27 — — US disclosed
US-20190055230-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2019-02-21 — — US disclosed
US-20190055230-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2019-02-21 — — US disclosed
EP-3144307-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB Science (FR) 2017-03-22 — — EP disclosed
EP-3144307-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB Science (FR) 2017-03-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190055230-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK SYK, BTK, LCK SYK 1/4885SMG1 968/4885CDK1 614/4885
US-10392373-B2 Oxazole derivatives that inhibit Syk SYK, BTK, LCK SYK 1/4885SMG1 950/4885CDK1 555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback